{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-22-000163","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2022-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.721321+00:00","generated_at":"2026-06-25T01:12:32.940246+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Tandem Diabetes appoints Myoung Cha and Joao Malagueira to board","bullets":["Myoung Cha elected Class III director effective June 15, 2022; will serve on Compensation Committee.","Cha is President & CSO at Carbon Health; previously Head of Health Strategic Initiatives at Apple.","Joao Malagueira elected Class I director effective June 15, 2022; will serve on Audit Committee.","Malagueira is VP for three divisions at Hologic; 25+ years experience in diabetes and medical devices.","Board size increased from nine to ten directors; both new directors are independent under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-22-000163","json":"https://secwatch.observer/filing/0001438133-22-000163.json","markdown":"https://secwatch.observer/filing/0001438133-22-000163.md","text":"https://secwatch.observer/filing/0001438133-22-000163.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000163/0001438133-22-000163-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000163/tndm-20220615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:12:32.940246+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"95267bec00","claim":"Joao Malagueira was elected as Director at TANDEM DIABETES CARE INC.","evidence_excerpt":"elected Joao Malagueira, age 56, to serve as a Class I director on the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000163/0001438133-22-000163-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"eec83efc2e","claim":"Myoung Cha was elected as Director at TANDEM DIABETES CARE INC.","evidence_excerpt":"elected Myoung Cha, age 45, to serve as a Class III director on the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000163/0001438133-22-000163-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}